As Sanofi and Regeneron await the FDA decision, a legal dispute between the partners over commercialisation details continues ...
The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for ...
Theratechnologies Inc. ("Theratechnologies" or the "Company") , a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback